Recent studies suggest that impairment in ADA regulation or isoenzyme distribution is associated with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis [224,258,259], although the mechanism leading to neurodegeneration is not clear at the moment. This evidence concerns the gene ADA and amyotrophic lateral sclerosis.